Aclarion (ACONW) Long-Term Debt Issuances (2021 - 2023)
Aclarion posted quarterly Long-Term Debt Issuances of $250000.0 for Q4 2023, down 66.67% on a QoQ basis from $750000.0 in Q3 2023.
Aclarion (ACONW) has 2 years of Long-Term Debt Issuances data on file, last reported at $250000.0 in Q4 2023.
- For the quarter ending Q4 2023, Long-Term Debt Issuances changed N/A year-over-year to $250000.0; the trailing twelve-month figure through Dec 2023 stood at $1.0 million (changed N/A YoY), and the FY2023 full-year result was $2.2 million, changed N/A from the prior year.
- Long-Term Debt Issuances for Q4 2023 stood at $250000.0, down from $750000.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $1.2 million in Q4 2021 and bottomed at -$69000.0 in Q2 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn | - |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn | - |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn | - |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn | - |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn | - |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn | 19.80 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn | - |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn | - |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn | - |
| 10 | Aclarion | - | - | 3,750.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 250,000.00 |
| Dec 31, 2023 | 250,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Sep 30, 2023 | 750,000.00 |
| Dec 31, 2021 | 1.19 Mn |
| Dec 31, 2021 | 1.19 Mn |
| Sep 30, 2021 | 689,500.00 |
| Sep 30, 2021 | 689,500.00 |
| Jun 30, 2021 | -69,000.00 |
| Jun 30, 2021 | -69,000.00 |
| Mar 31, 2021 | 194,000.00 |
| Mar 31, 2021 | 194,000.00 |